|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 10, 2016 ) About Next-generation Biologics
According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition or disease of human beings. Biologic therapeutics include virus, toxins, allergenic products, therapeutic serums, antitoxin, blood components or derivatives, vaccines, blood, proteins (except any chemically synthesized polypeptide), or analogous products, or arsphenamine or derivative of arsphenamine intended for the treatment, prevention, or cure of a disease or condition. The differences between the small molecules and biologics includes the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics usually have a higher molecular weight and a complex molecular structure. They are usually derived from living organisms, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures and light.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=892950
Technavios analysts forecast the global Next-generation Biologics market to grow at a CAGR of 14.42% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global next-generation biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of next-generation biologics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market during the forecast period.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Read All Cardiovascular Devices Market Research Reports @ http://www.researchmoz.us/cardiovascular-devices-market-reports-61.html
Table of Contents
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Five forces analysis
PART 06: Market segmentation by application
Global regenerative medicine market
Global next-generation antibodies market
Global next-generation insulin products market
Global next-generation recombinant coagulation factors market
PART 07: Geographical segmentation
Next-generation biologics market in Americas
Next-generation biologics market in EMEA
Next-generation biologics market in APAC
PART 08: Market drivers
Increase in demand for ADCs
Advanced technological innovations
Reimbursement support for next-generation biologics
Special regulatory drug designations for biologics
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
